20.12.2024 07:58 | FUM | Holding(s) in Company | RNS |
02.12.2024 07:00 | FUM | Block Listing Six Monthly Return | RNS |
15.11.2024 07:00 | FUM | TR-1: Notification of major holdings | RNS |
04.11.2024 10:57 | FUM | Futura Medical progresses study of female sexual dysfunction treatment | Alliance |
04.11.2024 07:00 | FUM | Encouraging New Product Development Pipeline | RNS |
31.10.2024 07:00 | FUM | Total Voting Rights | RNS |
17.10.2024 14:00 | FUM | Clinical trial data presented at SMSNA | Reach |
07.10.2024 11:06 | HLN, FUM | IN BRIEF: Futura Medical US pre-orders trigger milestone payment | Alliance |
07.10.2024 07:00 | FUM | Further milestone payment triggered post US launch | RNS |
01.10.2024 07:00 | FUM | Total Voting Rights | RNS |
11.09.2024 17:43 | FUM | Trinity Delta research note & consensus forecasts | RNS |
10.09.2024 21:21 | ESO, LINV, ENSI | EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit | Alliance |
10.09.2024 07:00 | FUM | Futura Medical - Interim Results 2024 | RNS |
03.09.2024 11:31 | TRX, ATR, SQZ | UK earnings, trading statements calendar - next 7 days | Alliance |
02.09.2024 15:35 | HLN, FUM | IN BRIEF: Futura Medical's Eroxon to be available in US from October | Alliance |
02.09.2024 11:28 | NEO, JOG, FUM | AIM WINNERS & LOSERS: Futura Medica celebrates Eroxon launch in US | Alliance |
02.09.2024 10:47 | FUM | Update on US Launch | RNS |
02.09.2024 07:00 | FUM | Update on US launch | RNS |
19.08.2024 07:00 | FUM | Notice of Results | RNS |
01.08.2024 11:21 | HLN, OMI, FUM | AIM WINNERS & LOSERS: Futura Medical gets boost from Haleon push in US | Alliance |
01.08.2024 07:05 | FUM | Update on US launch | RNS |
01.07.2024 14:13 | FUM | Total Voting Rights | RNS |
01.07.2024 07:00 | FUM | Nominated Adviser and Joint Broker | RNS |
20.06.2024 20:02 | GTC, HOT, KETL | EARNINGS AND TRADING: Lords trading in line; Time Out trading ahead | Alliance |
20.06.2024 16:12 | FUM | Result of AGM | RNS |
20.06.2024 07:00 | FUM | AGM Statement | RNS |
13.06.2024 16:05 | THR, KETL, CODE | UK shareholder meetings calendar - next 7 days | Alliance |
31.05.2024 07:00 | FUM | Block Listing Six Monthly Review | RNS |
24.05.2024 07:00 | FUM | Notice of AGM and availability of Annual Report | RNS |
29.04.2024 07:00 | FUM | Directors’ / PDMR Dealing and Grant of Options | RNS |
10.04.2024 10:49 | FUM | Futura Medical hails results as erectile dysfunction drug drives sales | Alliance |
10.04.2024 07:00 | FUM | Results for the Year ended 31 December 2023 | RNS |
03.04.2024 12:58 | TSCO, MSLH, FUM | UK earnings, trading statements calendar - next 7 days | Alliance |
25.03.2024 07:00 | FUM | Notice of Results and Investor Presentation | RNS |
14.02.2024 09:24 | FUM | IN BRIEF: Futura Medical's Eroxon to soon be available on prescription | Alliance |
14.02.2024 07:00 | FUM | Eroxon to be available on prescription | Reach |
06.02.2024 12:24 | HLN, FUM | Futura Medical shares surge after "transformational year" | Alliance |
17.01.2024 07:00 | FUM | Director/PDMR Dealing | RNS |
17.01.2024 07:00 | FUM | Remuneration of Non-Exec Directors & Voting Rights | RNS |
15.01.2024 08:35 | FUM | Futura Medical extends licensing deal for erectile dysfunction gel | Alliance |
15.01.2024 07:00 | FUM | Futura Medical extends collaboration with Cooper | RNS |
09.01.2024 07:00 | FUM | Appointment of Roy Davis as Non-Executive Director | RNS |
30.11.2023 15:10 | FUM | Total Voting Rights | RNS |
30.11.2023 15:10 | FUM | Block Listing Six Monthly Return | RNS |
07.11.2023 17:47 | LUCE, FUM, VNET | TRADING: Zambeef sees profit above market views; Luceco trades in line | Alliance |
07.11.2023 07:00 | FUM | Futura expands partnership with M8 Pharmaceuticals | RNS |
02.11.2023 15:34 | FUM | Eroxon Awarded “New Product of the Year” by Boots | Reach |
31.10.2023 07:00 | FUM | Block Listing Application and Total Voting Rights | RNS |
25.10.2023 12:21 | FUM | Futura Medical gets Mexico marketing authorisation for Eroxon gel | Alliance |
25.10.2023 07:00 | FUM | Eroxon® Granted Marketing Authorisation in Mexico | Reach |
19.10.2023 14:17 | FUM | IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE | Alliance |
19.10.2023 07:00 | FUM | Eroxon Launches in the United Arab Emirates | Reach |
10.10.2023 07:00 | FUM | Directors’/PDMR Dealing and Grant of Options | RNS |
02.10.2023 12:13 | FUM | IN BRIEF: Futura Medical granted European patent for ED treatment | Alliance |
02.10.2023 07:00 | FUM | European Patent Granted for MED3000 until 2040 | RNS |
18.09.2023 11:28 | ADF, PET, DORE | TRADING UPDATES: Elixirr record half-year revenue; Bango profit down | Alliance |
18.09.2023 07:00 | FUM | Futura Medical - Interim Results 2023 | RNS |
11.09.2023 15:44 | SFOR, PHNX, HGT | UK earnings, trading statements calendar - next 7 days | Alliance |
18.08.2023 07:00 | FUM | Futura Medical - Notice of Interim Results | RNS |
09.08.2023 12:07 | FUM | IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia | Alliance |
09.08.2023 07:00 | FUM | MED3000 Commercialisation Approval in Saudi Arabia | RNS |
31.07.2023 07:00 | FUM | Futura Medical - Total Voting Rights | RNS |
18.07.2023 14:16 | FUM | Futura Medical chair steps down, promotes non-executive director | Alliance |
18.07.2023 11:04 | FUM | Board Change | RNS |
17.07.2023 09:13 | HLN, FUM | Futura Medical agrees US licensing deal with Haleon for Med3000 gel | Alliance |
17.07.2023 07:00 | FUM | Futura/Haleon Enter US Commercialisation Agreement | RNS |
30.06.2023 07:00 | FUM | Futura Medical - Total Voting Rights | RNS |
23.06.2023 16:30 | FUM | Recording of Investor Seminar | Reach |
22.06.2023 15:19 | FUM | Futura Medical Annual General Meeting Results | RNS |
22.06.2023 14:45 | FUM | IN BRIEF: Futura Medical hails continued momentum after Eroxon launch | Alliance |
22.06.2023 07:00 | FUM | Futura Medical AGM Statement | RNS |
19.06.2023 10:25 | FUM | Correction - TR-1: Notification of major holdings | RNS |
16.06.2023 16:05 | FUM | TR-1: Notification of major holdings | RNS |
15.06.2023 15:51 | WTB, TRLS, TM17 | UK shareholder meetings calendar - next 7 days | Alliance |
12.06.2023 10:13 | OVB, TUN, FUM | AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed | Alliance |